CTTN and inflammatory bowel disease: On the other hand, in patients with inflammatory bowel disease (IBD), decreased cortactin levels and loss of co-localization with ZO-1 were associated with intestinal epithelial barrier dysfunction (Citalan-Madrid et al., 2017).